公开(公告)号：US20170209390A1

公开(公告)日：2017-07-27

申请号：US15321819

申请日：2015-06-29

申请人： GW Pharma Limited

发明人： Colin Stott ,  Nick Jones ,  Benjamin Whalley ,  Gary Stephens ,  Claire Williams

IPC分类号： A61K31/05 ,  A61K9/08 ,  A61K9/00 ,  A61K45/06

CPC分类号： A61K31/05 ,  A61K9/0019 ,  A61K9/08 ,  A61K45/06 ,  A61K2300/00

摘要： The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy. Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.